TIM-3 and PD-1 co-blockades reverse the tumor progression induced by HPD in ID8VEGF-bearing mice during anti-PD-1 treatment by enhancing the function of CD8+TILs and TIDCs. This evidence concerns the gene PDCD1 and neoplasm.